We transform the most promising oncology innovations into highly competitive opportunities that benefit patients, researchers, investors, and Ontario's economy. Cancer Breakthroughs. Realized.


We know the business of science.


We bridge the funding gap.

Investment Opportunities

We are the gateway to Ontario's oncology assets.

FACIT in the News - @globeandmail

"U.S. biotech giant Celgene invests in Ontario-developed blood-cancer drug in potential $1-billion deal", January 29, 2019

https://www.theglobeandmail.com/business/ article-us-biotech-giant-celgene-invests-in-ontario-developed-blood-cancer/

FACIT and Triphase Accelerator Announce New Partnership with Celgene for First-in-class WDR5 Leukemia Therapy

Largest transaction to date for Canadian-discovered preclinical asset arises from Ontario collaborators

Triphase Accelerator, together with its majority shareholder FACIT, today announced a new strategic collaboration with Celgene for a first-in-class preclinical therapeutic targeting the WDR5 protein for the treatment of blood cancers including leukemia.

FACIT Makes Follow-on Investment in AI-based genomics company, DNAstack

Capital leverages Ontario’s strengths in genomics and informatics, deepens FACIT’s tech portfolio

FACIT's Compass Rose Oncology Fund is providing the follow-on investment. DNAstack also previously received capital from FACIT's early-stage Prospects Oncology Fund, illustrating FACIT's strategy to ensure promising companies grow roots and scale up in Ontario.

FACIT Features: Portfolio company KA Imaging launches first-in-human pilot study to test lung screening x-ray

FACIT congratulates portfolio company KA Imaging on significant clinical development milestone.

KA Imaging, a recent Prospects Fund recipient, is partnering with Grand River Hospital to conduct a pilot study on the use of a high-resolution multi-energy digital x-ray imager for patients with lung nodules.

FACIT Welcomes Har Grover and Ken Lawless to the Board

Strategic appointments of seasoned entrepreneurs add expertise and strengthen governance

Both leaders are passionate supporters of the Ontario life science sector, have broad industry experience and decades of work with entrepreneurial ventures.

Home Popup

Latest Tweet / Follow

Contact Us